Dr. Inamul Hasan Madar is a leading scientist and academician in cancer proteogenomics, with expertise in translational oncology, bioinformatics, and multi-omics integration. He holds a Ph.D. in Biochemistry from Korea University, where he developed innovative pipelines like mPE-MMR and Phospho-UMC for mass spectrometry data refinement. His landmark study published in Nature Cancer revealed novel tumor subtypes in pancreatic cancer. Currently an Associate Professor and researcher at CIODS, Yenepoya University, he mentors Ph.D. students, has over 18 patents, and has authored 15+ books/chapters. Dr. Madar founded Sana Hospital and Healthcare and eDOmics Private Ltd with Aeon Informatics, offering internships and bioinformatics training, and is pioneering AI-based biomarker discovery. He also leads a women’s wellness nutraceutical startup focused on herbal formulations for menstrual comfort. Recognized with multiple awards for mentorship and innovation, he serves as a scientific advisor and speaker in genomics and continues to build collaborations in precision medicine and omics research globally.